Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Clinical Genitourinary Cancer|July 24, 2019
Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate CancerJudith Stangl-Kremser, Ursula Lemberger, Melanie R Hassler, et al.
Contemporary Clinical Trials|April 4, 2023
Study protocol for a prospective, multi-centered randomized controlled trial comparing pelvic fascia-sparing radical prostatectomy with conventional robotic-assisted prostatectomy: The PARTIAL trialJudith Stangl-Kremser, Keith Kowalczyk, Edward M Schaeffer, et al.
Prostate Cancer and Prostatic Diseases|September 30, 2020
Differential impact of radiation therapy after radical prostatectomy on recurrence patterns: an assessment using [68Ga]Ga-PSMA ligand PET/CT(MRI)Bernhard Grubmüller, Victoria Jahrreiss, Nicolai Huebner, et al.
Scandinavian Journal of Urology|January 25, 2020
Comparative effectiveness of radical cystectomy and radiotherapy without chemotherapy in frail patients with bladder cancerDavid D'Andrea, Francesco Soria, Sonja Zehetmayer, et al.
The Prostate|January 24, 2025
Baseline Imaging Derived Factors of Response Following [225Ac]Ac-J591 Therapy in Metastatic Castration-Resistant Prostate Cancer: A Lesion Level AnalysisJudith Stangl-Kremser, Andres Ricaurte-Fajardo, Sandra Huicochea Castellanos, et al.
Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals|February 25, 2020
The prognostic impact of tumour NSD2 expression in advanced prostate cancerJudith Stangl-Kremser, Ursula Lemberger, Melanie R Hassler, et al.
Urology|August 26, 2021
Psoas Muscle Mass can Predict Postsurgical Outcomes in Patients Who Undergo Radical Cystectomy and Urinary Diversion ReconstructionJudith Stangl-Kremser, Hamed Ahmadi, Brian Derstine, et al.
The Prostate|July 10, 2023
Prognostic value of neutrophil-to-lymphocyte ratio in patients with metastatic castration-resistant prostate cancer receiving prostate-specific membrane antigen targeted radionuclide therapyJudith Stangl-Kremser, Michael Sun, Benedict Ho, et al.
Cancers|December 9, 2023
Analysis of the Tumor Immune Microenvironment (TIME) in Clear Cell Renal Cell Carcinoma (ccRCC) Reveals an M0 Macrophage-Enriched Subtype: An Exploration of Prognostic and Biological Characteristics of This Immune PhenotypeMark Farha, Srinivas Nallandhighal, Randy Vince, et al.
Urologic Oncology|January 19, 2020
Development of a prognostic model for survival time prediction in castration-resistant prostate cancer patientsJudith Stangl-Kremser, Andrea Mari, Rodrigo Suarez-Ibarrola, et al.
Pageof 3